The risks of long-term use of proton pump inhibitors: a critical review

M Jaynes, AB Kumar - Therapeutic advances in drug safety, 2019 - journals.sagepub.com
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …

[HTML][HTML] Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii

Y Nadatani, T Watanabe, W Suda, A Nakata… - Scientific reports, 2019 - nature.com
Proton pump inhibitors (PPIs) alter the composition of the intestinal microbiome,
exacerbating indomethacin (IND)-induced small intestinal damage. Vonoprazan fumarate …

Current updates in management of Clostridium difficile infection in cancer patients

M Aziz, R Fatima, LN Douglass… - Current Medical …, 2019 - Taylor & Francis
Background: Clostridium difficile infection (CDI) is a significant health burden, now
recognized as the leading cause of acquired diarrhea in patients receiving antibiotic …

Comparison of three criteria for potentially inappropriate medications in Chinese older adults

Z Ma, C Zhang, X Cui, L Liu - Clinical interventions in aging, 2019 - Taylor & Francis
Objectives This study aimed to compare the prevalence of potentially inappropriate
medications (PIMs) among Chinese aged patients using the Beers criteria of 2015, the …

Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of …

KM Mullane, ER Dubberke… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice address the prevention and management of Clostridium difficile …

[HTML][HTML] Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients

S Maeda, M Yamaguchi, K Maeda, N Kobayashi… - PLoS …, 2019 - journals.plos.org
Peritonitis is a major and the most significant complication of peritoneal dialysis (PD).
Although some predictors of peritonitis in PD patients are known, the association between …

A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults

M Inoue, T Yonemura, R de Solom, M Yamaji… - Vaccine, 2019 - Elsevier
Background Clostridium difficile infection (CDI) is a major global cause of nosocomial and
community-acquired infections. Despite potentially severe or fatal complications and …

Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile Infection

CE Figueroa Castro, LS Munoz-Price - Current Treatment Options in …, 2019 - Springer
Purpose of review We reviewed seminal papers and recently published articles discussing
multiple aspects of infection prevention applied to Clostridioides (formerly Clostridium) …

Practice measures for controlling and preventing hospital associated Clostridium difficile infections

D Ramai, A Noorani, A Ofosu, E Ofori, M Reddy… - Hospital …, 2019 - Taylor & Francis
Clostridium difficile (CD) is the most common cause of nosocomial diarrhea. We aim to
highlight practice measures for controlling and preventing Clostridium difficile infections …

Evaluating Clostridioides difficile Infection (CDI) Risk Factors by Comparing the Use of Piperacillin/Tazobactam, Cefepime, and Ceftazidime

S Rathod - 2019 - search.proquest.com
Introduction: Over the past several years, Clostridioides difficile infection (CDI) incidence has
been rising. The primary risk factor for CDI is antibiotic use. Many studies indicate that …